The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1.
CD8+ T cells play a key role in the in vivo control of HIV-1 replication via their cytolytic activity as well as their ability to secrete non-lytic soluble suppressive factors. Although the chemokines that naturally bind CCR5 (CCL3/MIP-1α, CCL4/MIP- 1β, CCL5/RANTES) are major components of the CD8-d...
Main Authors: | Christina Guzzo, Jamie Fox, Yin Lin, Huiyi Miao, Raffaello Cimbro, Brian F Volkman, Anthony S Fauci, Paolo Lusso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3873461?pdf=render |
Similar Items
-
Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles
by: Yuan Tian, et al.
Published: (2020-08-01) -
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells
by: Kazuhiko Matsuo, et al.
Published: (2018-11-01) -
Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma
by: Xian Chang, et al.
Published: (2021-01-01) -
Metamorphic Protein Folding Encodes Multiple Anti-<i>Candida</i> Mechanisms in XCL1
by: Acacia F. Dishman, et al.
Published: (2021-06-01) -
Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry
by: Raffaello Cimbro, et al.
Published: (2016-08-01)